String Bio: Financial Breakdown
Decoding financial health metrics of String Bio
Total Revenue₹16.5 Cr+16%Prev. FY
Total Expenses₹25.5 Cr+69%Prev. FY
Profit After Tax₹-9.0 Cr+-699%Prev. FY
Total Assets₹175.4 Cr+-3%Prev. FY
Net Profit Margin-54.7%-588%Prev. FY
FAQs on Financials of String Bio
No. In FY24, String Bio reported a net loss of ₹9.0 Cr+, so it was not profitable.
String Bio's revenue grew 16.4% year-on-year, from ₹14.2 Cr+ in FY23 to ₹16.5 Cr+ in FY24.
String Bio's estimated EBITDA for FY24 was ₹-1.3 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, String Bio posted revenue of ₹16.5 Cr+ (up 16.4% YoY) and a net loss of ₹9.0 Cr+. Explore the full financials of String Bio here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links